Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management (Contemporary Hematology)

chronic Lymphocytic Leukemia (cll) Is The Second Most Frequently Encountered Leukemia In North America And Europe, And The Object Of Considerable Research And Treatment. In Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, And Management, Prominent Physicians And Researchers From The Leading Medical Centers In The United States And Europe Critically Review The Latest Scientific Advances In Our Understanding Of The Molecular Genetics And Biology Of Cll And Apply Them To Its Best Management. Their Comprehensive Reviews Of The Clinical Aspects Of Cll Focus On Diagnosis, Prognosis, Multifaceted Treatment Options, And Complications. Among The Diverse Treatments Considered Are Chemotherapy, Autologous And Allogeneic Transplantations, Monoclonal Antibody Therapy, Immunotoxin Therapy, Gene Therapy, And Several Promising New Therapeutic Strategies. Familial And Juvenile Chronic Lymphocytic Leukemia Are Also Discussed. cutting-edge And Clinically Focused, Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, And Management Offers Today's Hematologists And Oncologists The Opportunity To Update Their Clinical Knowledge And Sort Out The Range Of Available Therapies To Provide Optimal Patient Care.

A comprehensive and critical review of the latest scientific advances in our understanding of the molecular genetics and biology of CLL and their application to the best management of CLL. The authors focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogenic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, and several new therapeutic strategies. Familial and juvenile chronic lymphocytic leukemia are also discussed.

Veterans Affairs Medical Center, Augusta, GA. Reviews scientific advances in molecular genetics and biology of chronic lymphocytic leukemia. Discusses the clinical aspects, focusing on diagnosis, prognosis, treatment options, and complications. Also addresses familial and juvenile cases. DNLM: Leukemia, Lymphocytic, Chronic. Features a comprehensive review of the clinical aspects of chronic lymphocytic leukemia (CLL); discussion of the latest scientific advances in the molecular genetics and biology of CLL; extensive coverage of the multifaceted treatment options available for CLL; and coverage of all facets of chronic lymphocytic leukemia By convention, the history of chronic lymphocytic leukemia (CLL) begins in 1845, but it could be said to have started when the first white cells, "the globuli albicanates."